AKTX insider transaction filings

Akari Therapeutics Plc — 37 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen AKTX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-194Farag Kameel D. — Interim CFOGrant/award (A): 1,728 @ $7.52EDGAR
2026-08-054Farag Kameel D. — Interim CFOGrant/award (A): 1,130 @ $11.50EDGAR
2026-07-174Patel Samir Rashmikant — Director, 10% ownerOption exercise (M): 1,209 @ $8 · Option exercise (M): 15,466 @ $0.00 · Option exercise (M): 5,799 @ $0.00 · Option exercise (M): 1,209 (derivative) @ $32 · Option exercise (M): 15,466 (derivative) @ $16.16 · Option exercise (M): 5,799 (derivative) @ $16.16EDGAR
2026-06-254Farag Kameel D. — Interim CFOGrant/award (A): 1,248 @ $10.02 · Grant/award (A): 1,395 @ $9.32 · Grant/award (A): 1,570 @ $8.28 · Grant/award (A): 2,539 @ $5.12 · Grant/award (A): 3,725 @ $3.49 · Grant/award (A): 7,353 @ $3.74 · +1 moreEDGAR
2026-06-254Gaslightwala Abizer — CEO, DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 15,563 (derivative) @ $0EDGAR
2026-03-164Neal James R — DirectorPurchase (P): 2,473 (derivative) · Purchase (P): 2,473 (derivative) @ $0.40 · Purchase (P): 3,093 (derivative) · Purchase (P): 3,093 (derivative) @ $0.40EDGAR
2025-12-184Prudo-Chlebosz Raymond — DirectorPurchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 386,661 (derivative) · Purchase (P): 386,661 (derivative) @ $0.40EDGAR
2025-12-184Patel Sandip I — DirectorPurchase (P): 247,462 (derivative) · Purchase (P): 247,462 (derivative) @ $0.40 · Purchase (P): 154,664 (derivative) · Purchase (P): 154,664 (derivative) @ $0.40EDGAR
2025-12-184Farag Kameel D. — Interim CFOPurchase (P): 24,745 (derivative) · Purchase (P): 24,745 (derivative) @ $0.40EDGAR
2025-12-184Patel Samir Rashmikant — Director, 10% ownerPurchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 231,997 (derivative) · Purchase (P): 231,997 (derivative) @ $0.40EDGAR
2025-12-184Gaslightwala Abizer — CEO, DirectorPurchase (P): 309,328 (derivative) · Purchase (P): 309,328 (derivative) @ $0.40 · Purchase (P): 773,323 (derivative) · Purchase (P): 773,323 (derivative) @ $0.40EDGAR
2025-12-184Bazemore Robert B — DirectorPurchase (P): 123,731 (derivative) · Purchase (P): 123,731 (derivative) @ $0.40 · Purchase (P): 30,932 (derivative) · Purchase (P): 30,932 (derivative) @ $0.40EDGAR
2025-12-184Huh Hoyoung — Director, 10% ownerPurchase (P): 618,658 (derivative) · Purchase (P): 618,658 (derivative) @ $0.40 · Purchase (P): 3,093,293 (derivative) · Purchase (P): 3,093,293 (derivative) @ $0.40EDGAR
2025-11-044Farag Kameel D. — Interim CFOGrant/award (A): 32,000 @ $0.75 · Grant/award (A): 26,619 @ $0.75EDGAR
2025-10-244Farag Kameel D. — Interim CFOGrant/award (A): 6,277 @ $0.74EDGAR
2025-08-294Gaslightwala Abizer — CEO, DirectorPurchase (P): 10,000 @ $0.94 · Purchase (P): 8,000 @ $0.93 · Purchase (P): 3,000 @ $0.90EDGAR
2025-06-254Gaslightwala Abizer — President & CEO, DirectorPurchase (P): 943 @ $1.15 · Purchase (P): 5,203 @ $1.16EDGAR
2025-06-244Gaslightwala Abizer — President & CEO, DirectorPurchase (P): 10,000 @ $1.20EDGAR
2025-06-204Gaslightwala Abizer — President & CEO, DirectorPurchase (P): 15,000 @ $1.20EDGAR
2025-06-164Gaslightwala Abizer — CEO, DirectorGrant/award (A): 20,000 @ $1.23 · Grant/award (A): 25,000 @ $1.19EDGAR
2025-06-124Gaslightwala Abizer — CEO, DirectorGrant/award (A): 20,000 @ $1.27EDGAR
2025-04-294Patel Sandip I — DirectorGrant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12EDGAR
2025-03-244Neal James R — DirectorGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-244Bazemore Robert B — DirectorGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-244Patel Samir Rashmikant — DirectorGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-244Prudo-Chlebosz Raymond — DirectorGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-244Patel Sandip I — DirectorGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-244Hombeck Torsten — CFOGrant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0EDGAR
2025-03-244Gaslightwala Abizer — DirectorGrant/award (A): 1,100,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0EDGAR
2025-03-244Huh Hoyoung — Director, 10% ownerGrant/award (A): 175,000 (derivative) @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-03-104Prudo-Chlebosz Raymond — DirectorGrant/award (A): 446,428 @ $1.12 · Grant/award (A): 446,428 (derivative) @ $1.12 · Grant/award (A): 446,428 (derivative) @ $1.12EDGAR
2025-03-104Patel Samir Rashmikant — DirectorGrant/award (A): 406,250 @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12 · Grant/award (A): 406,250 (derivative) @ $1.12EDGAR
2025-03-104Neal James R — DirectorGrant/award (A): 4,464 @ $1.12 · Grant/award (A): 4,464 (derivative) @ $1.12 · Grant/award (A): 4,464 (derivative) @ $1.12EDGAR
2025-03-104Gaslightwala Abizer — DirectorGrant/award (A): 133,928 @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12 · Grant/award (A): 133,928 (derivative) @ $1.12EDGAR
2025-03-104Bazemore Robert B — DirectorGrant/award (A): 44,642 @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12 · Grant/award (A): 44,642 (derivative) @ $1.12EDGAR
2025-03-104Huh Hoyoung — Director, 10% ownerGrant/award (A): 892,857 @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12 · Grant/award (A): 892,857 (derivative) @ $1.12EDGAR
2025-02-074/AGaslightwala Abizer — DirectorGrant/award (A): 11,640 @ $1.22EDGAR

Recent 8-K events — Akari Therapeutics Plc

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-268-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-228-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-178-K3.03 — Material Modification to Rights of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-028-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-12-178-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-168-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-088-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-268-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AKTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →